HEADER TRANSPORT PROTEIN/IMMUNE SYSTEM 01-MAR-21 7LWD TITLE CRYO-EM STRUCTURE OF THE WILD-TYPE HUMAN SEROTONIN TRANSPORTER TITLE 2 COMPLEXED WITH VILAZODONE, IMIPRAMINE AND 15B8 FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM-DEPENDENT SEROTONIN TRANSPORTER; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: SERT,5HT TRANSPORTER,5HTT,SOLUTE CARRIER FAMILY 6 MEMBER 4; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HEAVY CHAIN ANTIBODY FRAGMENT; COMPND 8 CHAIN: H; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: LIGHT CHAIN ANTIBODY FRAGMENT; COMPND 11 CHAIN: L SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A4, HTT, SERT; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293 GNTI-; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 CELL_LINE: HYBRIDOMA; SOURCE 13 MOL_ID: 3; SOURCE 14 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 15 ORGANISM_TAXID: 10090; SOURCE 16 CELL_LINE: HYBRIDOMA KEYWDS ANTIDEPRESSANT, COMPLEX, TRANSPORTER, ANTIBODY, TRANSPORT PROTEIN, KEYWDS 2 TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR D.YANG,I.E.KALENDEROGLOU,E.GOUAUX,J.A.COLEMAN,C.J.LOLAND REVDAT 2 01-SEP-21 7LWD 1 JRNL REVDAT 1 11-AUG-21 7LWD 0 JRNL AUTH P.PLENGE,D.YANG,K.SALOMON,L.LAURSEN,I.E.KALENDEROGLOU, JRNL AUTH 2 A.H.NEWMAN,E.GOUAUX,J.A.COLEMAN,C.J.LOLAND JRNL TITL THE ANTIDEPRESSANT DRUG VILAZODONE IS AN ALLOSTERIC JRNL TITL 2 INHIBITOR OF THE SEROTONIN TRANSPORTER. JRNL REF NAT COMMUN V. 12 5063 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 34417466 JRNL DOI 10.1038/S41467-021-25363-3 REMARK 2 REMARK 2 RESOLUTION. 3.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CTFFIND, UCSF CHIMERA, PHENIX, REMARK 3 CRYOSPARC, CISTEM, RELION REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 6AWN REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : RIGID BODY FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.650 REMARK 3 NUMBER OF PARTICLES : 415288 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING ONLY REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7LWD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAR-21. REMARK 100 THE DEPOSITION ID IS D_1000255094. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : SEROTONIN TRANSPORTER 8B6 FAB REMARK 245 COMPLEX; SEROTONIN TRANSPORTER; REMARK 245 8B6 ANTIBODY REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 4.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4300.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 208 C1 NAG A 803 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 99 -23.93 -140.70 REMARK 500 ASN A 112 76.58 -101.87 REMARK 500 ILE A 154 -62.95 -107.33 REMARK 500 PRO A 196 47.06 -79.13 REMARK 500 LYS A 201 -167.11 -103.65 REMARK 500 THR A 210 -1.69 78.38 REMARK 500 TRP A 458 -169.30 -123.38 REMARK 500 ALA A 459 -4.64 69.10 REMARK 500 PHE A 465 -16.97 71.87 REMARK 500 SER A 611 50.89 -93.76 REMARK 500 THR A 616 74.06 51.85 REMARK 500 ILE H 67 -62.95 -93.37 REMARK 500 LYS H 82 -2.19 66.35 REMARK 500 ALA H 119 -168.14 -78.69 REMARK 500 ALA L 32 57.60 -94.71 REMARK 500 ALA L 108 -169.21 -161.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG A 803 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-23545 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF THE WILD-TYPE HUMAN SEROTONIN TRANSPORTER REMARK 900 COMPLEXED WITH VILAZODONE, IMIPRAMINE AND 15B8 FAB DBREF 7LWD A 77 617 UNP P31645 SC6A4_HUMAN 77 617 DBREF 7LWD H 20 137 PDB 7LWD 7LWD 20 137 DBREF 7LWD L 21 130 PDB 7LWD 7LWD 21 130 SEQRES 1 A 541 GLY GLU ARG GLU THR TRP GLY LYS LYS VAL ASP PHE LEU SEQRES 2 A 541 LEU SER VAL ILE GLY TYR ALA VAL ASP LEU GLY ASN VAL SEQRES 3 A 541 TRP ARG PHE PRO TYR ILE CYS TYR GLN ASN GLY GLY GLY SEQRES 4 A 541 ALA PHE LEU LEU PRO TYR THR ILE MET ALA ILE PHE GLY SEQRES 5 A 541 GLY ILE PRO LEU PHE TYR MET GLU LEU ALA LEU GLY GLN SEQRES 6 A 541 TYR HIS ARG ASN GLY CYS ILE SER ILE TRP ARG LYS ILE SEQRES 7 A 541 CYS PRO ILE PHE LYS GLY ILE GLY TYR ALA ILE CYS ILE SEQRES 8 A 541 ILE ALA PHE TYR ILE ALA SER TYR TYR ASN THR ILE MET SEQRES 9 A 541 ALA TRP ALA LEU TYR TYR LEU ILE SER SER PHE THR ASP SEQRES 10 A 541 GLN LEU PRO TRP THR SER CYS LYS ASN SER TRP ASN THR SEQRES 11 A 541 GLY ASN CYS THR ASN TYR PHE SER GLU ASP ASN ILE THR SEQRES 12 A 541 TRP THR LEU HIS SER THR SER PRO ALA GLU GLU PHE TYR SEQRES 13 A 541 THR ARG HIS VAL LEU GLN ILE HIS ARG SER LYS GLY LEU SEQRES 14 A 541 GLN ASP LEU GLY GLY ILE SER TRP GLN LEU ALA LEU CYS SEQRES 15 A 541 ILE MET LEU ILE PHE THR VAL ILE TYR PHE SER ILE TRP SEQRES 16 A 541 LYS GLY VAL LYS THR SER GLY LYS VAL VAL TRP VAL THR SEQRES 17 A 541 ALA THR PHE PRO TYR ILE ILE LEU SER VAL LEU LEU VAL SEQRES 18 A 541 ARG GLY ALA THR LEU PRO GLY ALA TRP ARG GLY VAL LEU SEQRES 19 A 541 PHE TYR LEU LYS PRO ASN TRP GLN LYS LEU LEU GLU THR SEQRES 20 A 541 GLY VAL TRP ILE ASP ALA ALA ALA GLN ILE PHE PHE SER SEQRES 21 A 541 LEU GLY PRO GLY PHE GLY VAL LEU LEU ALA PHE ALA SER SEQRES 22 A 541 TYR ASN LYS PHE ASN ASN ASN CYS TYR GLN ASP ALA LEU SEQRES 23 A 541 VAL THR SER VAL VAL ASN CYS MET THR SER PHE VAL SER SEQRES 24 A 541 GLY PHE VAL ILE PHE THR VAL LEU GLY TYR MET ALA GLU SEQRES 25 A 541 MET ARG ASN GLU ASP VAL SER GLU VAL ALA LYS ASP ALA SEQRES 26 A 541 GLY PRO SER LEU LEU PHE ILE THR TYR ALA GLU ALA ILE SEQRES 27 A 541 ALA ASN MET PRO ALA SER THR PHE PHE ALA ILE ILE PHE SEQRES 28 A 541 PHE LEU MET LEU ILE THR LEU GLY LEU ASP SER THR PHE SEQRES 29 A 541 ALA GLY LEU GLU GLY VAL ILE THR ALA VAL LEU ASP GLU SEQRES 30 A 541 PHE PRO HIS VAL TRP ALA LYS ARG ARG GLU ARG PHE VAL SEQRES 31 A 541 LEU ALA VAL VAL ILE THR CYS PHE PHE GLY SER LEU VAL SEQRES 32 A 541 THR LEU THR PHE GLY GLY ALA TYR VAL VAL LYS LEU LEU SEQRES 33 A 541 GLU GLU TYR ALA THR GLY PRO ALA VAL LEU THR VAL ALA SEQRES 34 A 541 LEU ILE GLU ALA VAL ALA VAL SER TRP PHE TYR GLY ILE SEQRES 35 A 541 THR GLN PHE CYS ARG ASP VAL LYS GLU MET LEU GLY PHE SEQRES 36 A 541 SER PRO GLY TRP PHE TRP ARG ILE CYS TRP VAL ALA ILE SEQRES 37 A 541 SER PRO LEU PHE LEU LEU PHE ILE ILE CYS SER PHE LEU SEQRES 38 A 541 MET SER PRO PRO GLN LEU ARG LEU PHE GLN TYR ASN TYR SEQRES 39 A 541 PRO TYR TRP SER ILE ILE LEU GLY TYR CYS ILE GLY THR SEQRES 40 A 541 SER SER PHE ILE CYS ILE PRO THR TYR ILE ALA TYR ARG SEQRES 41 A 541 LEU ILE ILE THR PRO GLY THR PHE LYS GLU ARG ILE ILE SEQRES 42 A 541 LYS SER ILE THR PRO GLU THR PRO SEQRES 1 H 118 GLN VAL GLN LEU GLN GLN SER GLY PRO GLU LEU VAL LYS SEQRES 2 H 118 LEU GLY ALA SER VAL ARG ILE SER CYS LYS ALA SER GLY SEQRES 3 H 118 TYR ARG PHE SER TYR SER TRP MET ASN TRP VAL LYS GLN SEQRES 4 H 118 ARG PRO GLY LYS GLY LEU GLU TRP ILE GLY ARG ILE TYR SEQRES 5 H 118 PRO GLY ASP GLY ASP THR LYS TYR SER GLY LYS PHE LYS SEQRES 6 H 118 GLY LYS ALA THR LEU THR ALA ASP LYS SER SER SER THR SEQRES 7 H 118 VAL TYR MET GLN LEU SER SER LEU THR SER GLU ASP SER SEQRES 8 H 118 ALA VAL TYR PHE CYS ALA ARG SER ALA TYR GLY SER GLU SEQRES 9 H 118 GLY PHE ALA MET ASP TYR TRP GLY GLN GLY THR SER VAL SEQRES 10 H 118 THR SEQRES 1 L 110 ASP ILE VAL LEU THR GLN SER PRO ALA SER LEU ALA VAL SEQRES 2 L 110 SER LEU GLY GLN ARG ALA THR ILE SER CYS ARG ALA SER SEQRES 3 L 110 GLU SER VAL ASP ASN TYR GLY ILE SER PHE LEU ASN TRP SEQRES 4 L 110 PHE GLN GLN LYS PRO GLY GLN PRO PRO LYS LEU LEU ILE SEQRES 5 L 110 TYR ALA ALA SER ASN GLN GLY SER GLY VAL PRO ALA ARG SEQRES 6 L 110 PHE SER GLY SER GLY SER GLY THR TYR PHE SER LEU ASN SEQRES 7 L 110 ILE HIS PRO MET GLU GLU ASP ASP THR ALA VAL TYR PHE SEQRES 8 L 110 CYS GLN GLN THR LYS GLY VAL SER TRP THR PHE GLY GLY SEQRES 9 L 110 GLY THR LYS VAL GLU ILE HET IXX A 801 21 HET YG7 A 802 66 HET NAG A 803 14 HETNAM IXX 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1- HETNAM 2 IXX AMINE HETNAM YG7 5-{4-[4-(5-CYANO-1H-INDOL-3-YL)BUTYL]PIPERAZIN-1-YL}-1- HETNAM 2 YG7 BENZOFURAN-2-CARBOXAMIDE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN IXX 5-(3-(DIMETHYLAMINO)PROPYL)-10,11-DIHYDRO-5H-DIBENZ[B, HETSYN 2 IXX F]AZEPINE;10,11-DEHYDROIMIPRAMINE;DEPRAMINE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 IXX C19 H24 N2 FORMUL 5 YG7 C26 H27 N5 O2 FORMUL 6 NAG C8 H15 N O6 HELIX 1 AA1 LYS A 84 VAL A 97 1 14 HELIX 2 AA2 LEU A 99 ASN A 112 1 14 HELIX 3 AA3 PHE A 117 GLY A 129 1 13 HELIX 4 AA4 GLY A 129 ARG A 144 1 16 HELIX 5 AA5 ILE A 150 CYS A 155 1 6 HELIX 6 AA6 PRO A 156 PHE A 158 5 3 HELIX 7 AA7 LYS A 159 SER A 189 1 31 HELIX 8 AA8 SER A 226 HIS A 235 1 10 HELIX 9 AA9 GLN A 238 SER A 242 5 5 HELIX 10 AB1 SER A 252 ILE A 270 1 19 HELIX 11 AB2 VAL A 280 ALA A 285 1 6 HELIX 12 AB3 THR A 286 LEU A 302 1 17 HELIX 13 AB4 ALA A 305 LEU A 313 1 9 HELIX 14 AB5 ASN A 316 LEU A 321 1 6 HELIX 15 AB6 GLU A 322 GLY A 338 1 17 HELIX 16 AB7 VAL A 343 SER A 349 1 7 HELIX 17 AB8 ASP A 360 ARG A 390 1 31 HELIX 18 AB9 ALA A 401 ILE A 408 1 8 HELIX 19 AC1 ILE A 408 MET A 417 1 10 HELIX 20 AC2 ALA A 424 PHE A 454 1 31 HELIX 21 AC3 PHE A 465 SER A 477 1 13 HELIX 22 AC4 GLY A 485 GLU A 494 1 10 HELIX 23 AC5 GLY A 498 TRP A 514 1 17 HELIX 24 AC6 GLY A 517 GLY A 530 1 14 HELIX 25 AC7 GLY A 534 ILE A 544 1 11 HELIX 26 AC8 ILE A 544 LEU A 557 1 14 HELIX 27 AC9 TYR A 572 SER A 585 1 14 HELIX 28 AD1 ILE A 587 THR A 600 1 14 HELIX 29 AD2 THR A 603 SER A 611 1 9 HELIX 30 AD3 ARG H 47 SER H 51 5 5 HELIX 31 AD4 LYS H 82 LYS H 86 1 5 HELIX 32 AD5 THR H 106 SER H 110 5 5 HELIX 33 AD6 TYR H 120 GLY H 124 5 5 SHEET 1 AA1 2 GLU H 29 LEU H 30 0 SHEET 2 AA1 2 VAL H 136 THR H 137 1 O THR H 137 N GLU H 29 SHEET 1 AA2 3 ARG H 38 LYS H 42 0 SHEET 2 AA2 3 THR H 97 LEU H 102 -1 O VAL H 98 N CYS H 41 SHEET 3 AA2 3 ALA H 87 ASP H 92 -1 N THR H 90 O TYR H 99 SHEET 1 AA3 4 LYS H 78 TYR H 79 0 SHEET 2 AA3 4 TRP H 66 ARG H 69 -1 N ARG H 69 O LYS H 78 SHEET 3 AA3 4 TRP H 55 GLN H 58 -1 N TRP H 55 O ILE H 67 SHEET 4 AA3 4 VAL H 112 PHE H 114 -1 O VAL H 112 N GLN H 58 SHEET 1 AA4 4 LEU L 24 SER L 27 0 SHEET 2 AA4 4 SER L 42 ALA L 45 -1 O ARG L 44 N THR L 25 SHEET 3 AA4 4 TYR L 94 SER L 96 -1 O PHE L 95 N CYS L 43 SHEET 4 AA4 4 SER L 89 SER L 91 -1 N SER L 89 O SER L 96 SHEET 1 AA5 2 SER L 30 LEU L 31 0 SHEET 2 AA5 2 LYS L 127 VAL L 128 1 O LYS L 127 N LEU L 31 SHEET 1 AA6 2 ASP L 50 ASN L 51 0 SHEET 2 AA6 2 ILE L 54 SER L 55 -1 O ILE L 54 N ASN L 51 SHEET 1 AA7 4 ASN L 77 GLN L 78 0 SHEET 2 AA7 4 LYS L 69 TYR L 73 -1 N TYR L 73 O ASN L 77 SHEET 3 AA7 4 LEU L 57 GLN L 61 -1 N TRP L 59 O LEU L 71 SHEET 4 AA7 4 CYS L 112 GLN L 114 -1 O GLN L 113 N ASN L 58 SSBOND 1 CYS A 200 CYS A 209 1555 1555 2.04 SSBOND 2 CYS H 41 CYS H 115 1555 1555 2.03 SSBOND 3 CYS L 43 CYS L 112 1555 1555 2.03 CISPEP 1 SER L 27 PRO L 28 0 -1.99 CISPEP 2 GLU L 47 SER L 48 0 22.50 CISPEP 3 GLY L 117 VAL L 118 0 1.63 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000